| An SI Board Since June 2001 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 4 |
2 |
0
|
NHTC |
|
"Our pick for June 10, 2001 is Irving, Texas based Natural Health Trends Corp., trading on the OTC Bulletin Board under the ticker symbol NHTC. The company, through a newly acquired majority controlled interest in Lexxus International, Inc., markets the most provocative and potentially profitable product since Viagra™… the product is a patented, all-natural, clear topical cream that assists in sexual stimulation for women. Women, since the beginning of recorded time, or at least since the introduction of Viagra™ in 1998, have been asking, “Where is mine?” Well, it’s here! Viacreme™ is an all natural and safe, non-prescription, clinically tested formula that has been shown to: increase intensity and frequency of orgasms, increase clitoral sensitivity, improve lubrication… and increase desire.
From ministers, to therapists, to John Gray, to Dr. Ruth, and to Oprah Winfrey, women and men across the U.S have struggled to find answers to better relationships and greater sexual satisfaction. The media has recently focused on the issue of female orgasm. Statistics indicate that one out of every three marital break-ups is due to sexual dysfunction. Over 46% of the women in America experience little or no sexual satisfaction from clitoral orgasm… and only 25% achieve orgasm with intercourse. In fact, countless numbers of women, between the ages of 18 and 80, do not even know what an orgasm is or how it is achieved… the Oprah Winfrey Show has called it the “Silent Epidemic”. Whether you are multi-orgasmic or are among the 46% of women who are sexually frustrated, every woman who desires maximum sexual fulfillment, greater intimacy, and enhanced relationships may potentially benefit from Viacreme™.
Viacreme™ is by-product of the 1998 Nobel Prize winning Medicine and Physiology award received for the discovery and understanding of the Nitric Oxide Pathway, the basis for penile and clitoral arousal, erection, and sensitivity. Viacreme™ is a specially compounded, all natural preparation, containing the active ingredients Menthol USP and L-arginine USP, an amino acid found in dietary products. When applied, the active ingredients in Viacreme™ stimulate the tissue surfaces, resulting in increased blood flow and dilation of the blood vessels in the clitoral area. Response time varies with each individual woman. Foreplay, sexual stimulation of touching and rubbing in the clitoral area, activates the pleasurable tingling, warming effects of Viacreme™.
The actual concentrations of the active ingredients are quite dilute, but because a woman’s genital tissues are extremely sensitive, application of Viacreme™ will stimulate a vigorous tingle. The product is compounded and individually packaged in a medical grade facility… wrapped in sanitary, individual pillow-packs, Viacreme™ is convenient to use, to store or to carry. It has also been laboratory evaluated for safety. Viacreme™ is water based and meets the FDA requirements for condom safety. And… yes, it is OK for oral sex.
The product developer, Ronald J.Thompson, M.D. is a Board Certified obstetrician/gynecologist, who has cared for women and their health care concerns for over twenty years. Dr. Thompson has experience in drug development and clinical drug evaluation, all within the focus of gynecology and infertility. Besides teaching surgery and surgical procedures, Dr. Thompson has numerous patents in infertility, women’s urinary incontinence, uterine bleeding, and women’s sexual responsiveness. Dr. Thompson is and has been a surgical consultant to a number of medical companies.
Viacreme™ retails for $11.95/pillow. Each pillow-pack contains sufficient product for 3 or 4 uses. Viacreme™ is marketed through a network of independent associates. Lexxus offers its sales associates several lucrative and retail oriented compensation plans. For more information on how to become part of the rapidly expanding Lexxus sales network go to this link: arrayint.com
Though extremely speculative, Stocksnake.com feels that NHTC offers incredible upside potential as Viacreme™ becomes more widely known and used. Viacreme™ was the subject of a recent network news segment… word is getting out. NHTC closed Friday at 7.2 cents on 1,491,900 shares traded. The company has only 73 million shares outstanding… small by OTC Bulletin Board standards. Readers are encouraged to visit the Lexxus website for further information. arrayint.com
Stocksnake.com did not receive compensation of any kind from the company or third parties for writing this report. Readers are urged to read the company SEC filings and do their own due diligence before investing in this or any other stock."
...reprinted from Stocksnake.com article (6/10/01)
|
